193 related articles for article (PubMed ID: 22997201)
21. A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.
Coccé MC; Lubieniecki F; Kordes U; Alderete D; Gallego MS
J Neurooncol; 2011 Aug; 104(1):375-80. PubMed ID: 21127945
[TBL] [Abstract][Full Text] [Related]
22. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
23. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
24. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
[TBL] [Abstract][Full Text] [Related]
25. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.
Lee RS; Stewart C; Carter SL; Ambrogio L; Cibulskis K; Sougnez C; Lawrence MS; Auclair D; Mora J; Golub TR; Biegel JA; Getz G; Roberts CW
J Clin Invest; 2012 Aug; 122(8):2983-8. PubMed ID: 22797305
[TBL] [Abstract][Full Text] [Related]
26. Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells.
Vu-Han TL; Frühwald MC; Hasselblatt M; Kerl K; Nagel I; Obser T; Oyen F; Siebert R; Schneppenheim R
Cancer Genet; 2014 Sep; 207(9):390-7. PubMed ID: 25016934
[TBL] [Abstract][Full Text] [Related]
27. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
[TBL] [Abstract][Full Text] [Related]
28. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.
Algar EM; Muscat A; Dagar V; Rickert C; Chow CW; Biegel JA; Ekert PG; Saffery R; Craig J; Johnstone RW; Ashley DM
PLoS One; 2009; 4(2):e4482. PubMed ID: 19221586
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
Kohashi K; Oda Y
Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
[TBL] [Abstract][Full Text] [Related]
31. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
32. [Rhabdoid tumours].
Vasovčák P; Puchmajerová A; Křepelová A
Klin Onkol; 2012; 25 Suppl():S27-9. PubMed ID: 22920203
[TBL] [Abstract][Full Text] [Related]
33. Rapid detection of SMARCB1 sequence variation using high resolution melting.
Dagar V; Chow CW; Ashley DM; Algar EM
BMC Cancer; 2009 Dec; 9():437. PubMed ID: 20003390
[TBL] [Abstract][Full Text] [Related]
34. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
35. Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.
Kerl K; Holsten T; Frühwald MC
Pediatr Hematol Oncol; 2013 Oct; 30(7):587-604. PubMed ID: 23848359
[TBL] [Abstract][Full Text] [Related]
36. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
[TBL] [Abstract][Full Text] [Related]
37. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
[TBL] [Abstract][Full Text] [Related]
38. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
[TBL] [Abstract][Full Text] [Related]
39. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529
[TBL] [Abstract][Full Text] [Related]
40. Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer.
Lee RS; Roberts CW
Brain Pathol; 2013 Mar; 23(2):200-5. PubMed ID: 23432645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
